E-DRUG: Expanding Global Access to Essential Medicines
----------------------------------------------------------------------
Continued and increased investment in medicines regulatory system strengthening will improve health outcomes and save lives. How do those investments need to be structured, though?
Published on Springer Nature, "Expanding Global Access to Essential Medicines: Investment Priorities for Sustainably Strengthening Medical Product Regulatory Systems," brings together some of the most notable global opinion leaders in medical products regulation. This key paper outlines seven focused strategies and 13 recommendations to address the three critical challenges that national regulatory authorities in low- and middle-income countries face:
-- Implementing value-added regulatory practices that best utilize available resources
-- A lack of timely access to new, quality medical products
-- Limited evidence-based data to support post-marketing regulatory actions
Paul Crystal
USP
Paul Crystal
paul.crystal@USP.org